Segal Trials proudly announces its participation in the successful Phase 2b NAVIGATE clinical trial conducted by Cidara ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...

H5N1, or bird flu, initially presents with common flu-like symptoms such as fever, cough, and fatigue, making early detection ...

A separate single arm will evaluate the effects of TXM in patients infected with H5N1 bird flu. The proposed study has been submitted for Human Research Ethics Committee (HREC) review and is expected ...

H5N1 bird flu can cause severe illness in humans. Experts warn it spreads from animals, not people, but can turn deadly if ...

Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...

CABANATUAN CITY (PIA) — The Department of Health (DOH) Central Luzon Center for Health Development (CLCHD) is reminding the ...

With Rising Variants of COVID and Bird Flu, the Single Broad-Spectrum Antiviral NV-387 Would be the Best Partner for Preparedness, Says NanoViricides’ Dr. Diwan Written by nanoviricides ...

Assess your risk of contracting H1N1 swine flu with our easy-to-use Swine Flu Risk Calculator. Identify risk factors, ...